Health & Fitness
Combo DAA May Benefit Patients With Resistant HCV Genotype 3
A meta-analysis of 34 research reports found that direct-acting antiviral (DAA) combo treatment can be effective in achieving sustained virologic response in patients with HCV genotype 3. Medscape Medical News
